Evaluating a Cardiology Quality Program for Heart Failure and Atrial Fibrillation
This observational study is looking at how well a program works that sends quarterly emails to heart doctors about ways to improve care for patients with heart failure with reduced ejection fraction (HFrEF) and atrial fibrillation (AFib). Researchers want to see if these emails help doctors prescribe the right medications to eligible patients. You might be able to join if you are 18 to 90 years old and have an active diagnosis of atrial fibrillation with a CHADS2VASC score of at least 2 (for males) or 3 (for females), or if you have HFrEF with a recent ejection fraction (EF) of 40% or less. You also need to have had an outpatient cardiology visit in the past three months. The study aims to enroll 7000 participants. The main goal is to measure the percentage of eligible patients who are prescribed these medications, measured on Day 1.
- Study design
- This is an observational study, meaning researchers will watch and collect information without giving any specific treatments. It plans to include 7000 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint is measured at Day 1, which suggests a short follow-up period for this specific measurement.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Subspecialty Ambulatory Quality Cardiology Program
At a glance
Conditions
NCT07283666
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
NYU Langone Health
New York, New Yorkno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Amrita Mukhopadhyay, MD · PRINCIPAL_INVESTIGATOR · NYU Langone Health
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Percentage of patients eligible for medications who are prescribed these medicationsDay 1